miR-200b/c attenuated lipopolysaccharide-induced early pulmonary fibrosis by targeting Zinc-finger E-box-binding homeobox 1/2 (ZEB1/2) via p38 mitogen-activated protein kinase (MAPK) and transforming growth factor-β (TGF-β)/smad3 signaling pathways [10]. Here, ZEB1 is linked to pulmonary fibrosis.